Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Other Non-Current Assets: 2022-2024

Historic Other Non-Current Assets for Entrada Therapeutics (TRDA) over the last 3 years, with Dec 2024 value amounting to $4.0 million.

  • Entrada Therapeutics' Other Non-Current Assets changed negligibly% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $4.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Entrada Therapeutics reported Other Non-Current Assets of $4.0 million as of FY2024, which was down 0.00% from $4.0 million recorded in FY2023.
  • Entrada Therapeutics' Other Non-Current Assets' 5-year high stood at $5.2 million during FY2022, with a 5-year trough of $4.0 million in FY2023.
  • Over the past 3 years, Entrada Therapeutics' median Other Non-Current Assets value was $4.0 million (recorded in 2024), while the average stood at $4.4 million.
  • Data for Entrada Therapeutics' Other Non-Current Assets shows a maximum YoY declined of 24.18% (in 2023) over the last 5 years.
  • Over the past 3 years, Entrada Therapeutics' Other Non-Current Assets (Yearly) stood at $5.2 million in 2022, then declined by 24.18% to $4.0 million in 2023, then remained steady at $4.0 million in 2024.